Items where authors include "Pei, H"

Article

San-Miguel, JF, Avet-Loiseau, H, Paiva, B et al. (24 more authors) (2022) Sustained Minimal Residual Disease Negativity With Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONE. Blood, 139 (4). pp. 492-501. ISSN 0006-4971

Cook, G orcid.org/0000-0001-7196-7364, Corso, A, Streetly, M et al. (11 more authors) (2021) Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia. Oncology and Therapy, 9. pp. 139-151. ISSN 2366-1070

Conference or Workshop Item

Kaufman, JL, Usmani, SZ, San-Miguel, J et al. (16 more authors) (2020) Four-Year Follow-up of the Phase 3 Pollux Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Relapsed or Refractory Multiple Myeloma (RRMM). In: 61st American Society of Hematology (ASH) Annual Meeting, 07-10 Dec 2019, Orlando, Florida, USA.